CCND1 and esophageal squamous cell carcinoma: To test if ATO treatment repressed cyclin D1 transcription, we measured cyclin D1 RNA levels with real-time PCR, and found no significant changes of cyclin D1 mRNA levels in ESCC and OSCC cells by ATO treatment (Figure 1C).